|Oxihumic Acids and Its Use in the Treatment of Various Conditions.|
|Patent #||Kind Date||Date||Application|
|WO 2000016786||A2||2000 03 30||WO|
|1999-IB1569||1999 09 22|
|WO 2000016786||A3||2000 06 08|
A pharmaceutical compound comprising an oxihumic acid salt, ester or derivatives thereof as an active ingredient is disclosed. The compound. is preferably administered orally for stimulating lymphocytes in a human, animal or bird. It may be used in treating viral and bacterial infections, HIV infections, opportunistic diseases, inflammation, pain and fever, cancer growth and diseases associated with viral infection and a depressed immune system. A number of pharmacological examples were given including interleukin 10 production by oxihumate treated lymphocytes, increased antibody production against Newcastle disease in chickens treated with oxihumate, TNF production by oxihumate treated lymphocytes, and antiviral activity of oxihumate against HSV-1 and coxsackie virus type 1 in vitro.
DISCLAIMER: This website presents a collection of statements from around the world about the benefits of Humic Acid. This information is provided for informational purposes only. These statements were variously made over several decades of time. There are many sources of Humic Acid around the globe, and they differ significantly in their physical and chemical properties. This website does not intend to provide medical advice, nor does it intend to suggest that all Humic Acid preparations will be of equal benefit. Nothing herein is intended to be an endorsement of or a solicitation to purchase any particular Humic Acid preparation. The FDA has not evaluated any statement made on this website. The information herein is not intended to diagnose any disease, nor is it intended to prescribe any preparation that claims to diagnose, treat, cure or prevent any disease.